This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Horizon Pharma PLC
HZNP : NASDAQ : Health Care
$21.81 up0.13 | 0.60%
Today's Range: 21.44 - 22.69
Avg. Daily Volume: 7,503,400
11/25/15 - 4:00 PM ET

PEER GROUP: Pharmaceuticals

Ticker Company Name Recent
Net Sales
Net Income
HZNP HORIZON PHARMA PLC 18.82 2997.89 n/m 616.35 176.14
MNK MALLINCKRODT PLC 60.08 7049.97 n/m 3530.60 53.75
TARO TARO PHARMACEUTICL INDS LTD 138.24 5921.23 11.13 909.22 16.29
AKRX AKORN INC 32.46 3714.50 111.93 593.08 86.67
CTLT CATALENT INC 27.26 3394.47 14.27 1835.50 31.95
IPXL IMPAX LABORATORIES INC 42.90 3025.05 115.95 709.59 25.46
MDCO MEDICINES CO 41.23 2863.18 n/m 480.66 -33.10
PBH PRESTIGE BRANDS HOLDINGS 49.13 2591.46 25.32 785.85 27.80
ITCI INTRA-CELLULAR THERAPIES INC 51.56 2218.27 n/m 0.13 -90.59
PCRX PACIRA PHARMACEUTICALS INC 58.81 2161.68 235.24 241.47 42.50
NKTR NEKTAR THERAPEUTICS 14.95 1995.09 n/m 210.97 -0.63
The peer group comparison is based on Major Pharmaceuticals companies of comparable size.

Price Earnings Comparison

HZNP Ind Avg S&P 500
n/m 28.30 21.93

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Real Money
Try it NOW

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs